Table 7.
Crude and age-standardized rates of cancer prevalence by sex on January 1, 2020 in Korea
| Site/Type | Crude prevalence rate per 100,000a) | Age-standardized prevalence rate per 100,000b) | ||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| Both sexes | Men | Women | Both sexes | Men | Women | |
| All sites | 4,433.9 | 3,901.2 | 4,963.8 | 2,373.6 | 2,121.4 | 2,708.5 |
|
| ||||||
| Lip, oral cavity, and pharynx | 61.2 | 81.8 | 40.8 | 33.4 | 45.8 | 22.3 |
|
| ||||||
| Esophagus | 24.7 | 44.0 | 5.5 | 11.4 | 22.1 | 2.4 |
|
| ||||||
| Stomach | 643.1 | 850.9 | 436.4 | 304.5 | 436.8 | 194.1 |
|
| ||||||
| Colon and rectum | 569.8 | 676.7 | 463.4 | 267.5 | 350.3 | 199.5 |
|
| ||||||
| Liver | 151.8 | 227.4 | 76.6 | 77.2 | 122.3 | 36.0 |
|
| ||||||
| Gallbladderc) | 52.0 | 53.8 | 50.2 | 22.9 | 27.0 | 19.7 |
|
| ||||||
| Pancreas | 32.0 | 32.4 | 31.6 | 16.3 | 17.4 | 15.6 |
|
| ||||||
| Larynx | 23.9 | 45.0 | 2.8 | 10.9 | 22.6 | 1.2 |
|
| ||||||
| Lung | 216.6 | 258.7 | 174.7 | 101.5 | 131.0 | 78.8 |
|
| ||||||
| Breast | 545.2 | 4.0 | 1,083.6 | 307.6 | 2.1 | 606.2 |
|
| ||||||
| Cervix uteri | 117.8 | - | 234.9 | 65.2 | - | 128.0 |
|
| ||||||
| Corpus uteri | 65.8 | - | 131.2 | 37.1 | - | 73.2 |
|
| ||||||
| Ovary | 50.0 | - | 99.8 | 30.8 | - | 61.4 |
|
| ||||||
| Prostate | 234.5 | 470.3 | - | 96.5 | 223.9 | - |
|
| ||||||
| Testis | 8.5 | 17.1 | - | 7.6 | 14.8 | - |
|
| ||||||
| Kidney | 106.4 | 144.4 | 68.6 | 57.9 | 82.0 | 35.8 |
|
| ||||||
| Bladder | 81.5 | 133.1 | 30.1 | 35.7 | 66.5 | 11.6 |
|
| ||||||
| Brain and CNS | 26.1 | 26.9 | 25.3 | 21.2 | 22.5 | 19.9 |
|
| ||||||
| Thyroid | 953.6 | 357.5 | 1,546.6 | 587.8 | 226.8 | 947.2 |
|
| ||||||
| Hodgkin lymphoma | 7.1 | 8.8 | 5.4 | 5.7 | 6.8 | 4.6 |
|
| ||||||
| Non-Hodgkin lymphoma | 79.6 | 90.5 | 68.7 | 50.5 | 60.4 | 41.1 |
|
| ||||||
| Multiple myeloma | 16.2 | 17.1 | 15.3 | 7.9 | 9.0 | 7.0 |
|
| ||||||
| Leukemia | 52.9 | 58.8 | 47.0 | 46.0 | 51.4 | 40.6 |
|
| ||||||
| Other and ill-defined | 313.7 | 302.0 | 325.3 | 170.4 | 180.1 | 162.4 |
CNS, central nervous system.
a)
Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2020 and who were alive on January 1, 2021. Multiple primary cancer cases were counted multiple times,
b)
Age-adjusted using the Segi’s world standard population,
c)
Includes the gallbladder and other/unspecified parts of the biliary tract.